Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients

BACKGROUND: Bone marrow angiogenesis is increased in multiple myeloma (MM) patients, prompting the rationale for using antiangiogenic drugs in the treatment of these patients. OBJECTIVE: To assess angiogenesis in patients with MM at diagnosis and following treatment with an antiangiogenic drug. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Cury, Priscilla Cury de Camargo, Higashi, Fabiana, Zacchi, Flávia Fernandes Silva, Palhares, Renata Bacic, Quero, Adriana Alvares, Dias, Ana Luiza Miranda Silva, Crusoé, Edvan de Queiroz, Hungria, Vania Tietsche de Moraes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248500/
https://www.ncbi.nlm.nih.gov/pubmed/31519532
http://dx.doi.org/10.1016/j.htct.2019.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248500/
https://www.ncbi.nlm.nih.gov/pubmed/31519532
http://dx.doi.org/10.1016/j.htct.2019.04.006

Ejemplares similares